ResMed | RMD - Sales Revenues

Stock Price
222.03
Daily Change
2.18 0.99%
Monthly
0.91%
Yearly
-5.17%
Q2 Forecast
215.15

ResMed reported $1.4B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Ansell USD 1.03B 192.2M Dec/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 140.5M 6.2M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Cochlear AUD 1.18B 590.35M Dec/2025
Cooper Companies USD 1.02B 41.1M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.65B 80M Mar/2026
Fisher Paykel Healthcare NZD 1.1B 21.3M Dec/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
Masimo USD 412.5M 41M Dec/2025
Medtronic USD 9B 39M Jan/2026
Philips EUR 5.1B 797M Dec/2025
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
ResMed USD 1.4B 100M Dec/2025
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Sonic Healthcare AUD 5.45B 470M Dec/2025
Steris USD 1.5B 470M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026